Asabys and Buenavista led a $50m Series A round in Quibim.

Asabys, a life science venture capital firm, and Buenavista, a private equity firm, led a $50m Series A round in Quibim, a company developing AI-powered radiomics and imaging biomarkers, with participation from UI Investissements, GoHub, CDTI Innovación, Amadeus, APEX, Partech, Adara Ventures, Leadwind, Build Collective and Jonathan Milner. “Quibim’s mission is to turn imaging into a catalyst for precision health, and we are deeply grateful to both our new and current investors for their support [...] Our global expansion into the U.S. is a critical milestone as we work with pharmaceutical leaders and healthcare providers to unlock the power of imaging to revolutionize diagnostics and improve patient outcomes,” Angel Alberich-Bayarri, Quibim CEO and Co-Founder.